INDP Stock Analysis: Buy, Sell, or Hold?
INDP - Indaptus Therapeutics, Inc. Common Stock
$3.58
0.01 (0.28%)
▲
5d:
-2.19%
30d:
+104.57%
90d:
+102.26%
WAIT
LOW Confidence
Analysis Updated: Jun 12, 2026 12:00 AM ET
Earnings: May 13, 2026
0d
Get Alerted When INDP Hits Your Target Price
Join 10,000+ traders who never miss a move
You're in! Check your email to confirm and set your target price.
100% Free
No spam, ever
Unsubscribe anytime
Interactive Price Chart (1 Month)
Loading chart...
Loading historical data...
Bottom Line:
⏸️ WAIT FOR BETTER ENTRY: INDP is 28.3% above its trading range ($2.79). While momentum could continue, risk/reward favors waiting for a pullback.
⏸️ WAIT FOR BETTER ENTRY: INDP is 28.3% above its trading range ($2.79). While momentum could continue, risk/reward favors waiting for a pullback.
In-depth Analysis How we analyze
Valuation Analysis: INDP is currently trading at $3.58, which is considered extended relative to its 30-day fair value range of $1.18 to $2.79.
Technical Outlook: Technically, INDP is showing sideways momentum. Immediate support is located at $1.74, while resistance sits at $5.96.
Market Sentiment: INDP has a strong technical setup (60/100), with favorable trendlines, momentum, and price action for short-term traders. Wall Street analysts see significant upside, with an average price target of $10.00 (+179.3%). Current signals suggest waiting for a better entry point before initiating new positions.
Technical Outlook: Technically, INDP is showing sideways momentum. Immediate support is located at $1.74, while resistance sits at $5.96.
Market Sentiment: INDP has a strong technical setup (60/100), with favorable trendlines, momentum, and price action for short-term traders. Wall Street analysts see significant upside, with an average price target of $10.00 (+179.3%). Current signals suggest waiting for a better entry point before initiating new positions.
Quick Decision Summary
Current Position
EXTENDED
Historical Trading Range
$1.18 -
$2.79
Company Quality Score
50/100
(HOLD)
Volume Confirmation
MODERATE
Confidence Score
47.4%
All Signals
- BEARISH: Price significantly overextended (+28.3% above its trading range)
- BULLISH: Strong technical setup (60/100)
- BULLISH: Trading 179.3% below Wall St target ($10.00)
- WARNING: Recommendation downgraded due to 28.3% overvaluation
Trading Range Analysis
30-Day Trading Range
$1.18 -
$2.79
Current vs Trading Range
EXTENDED
Support & Resistance Levels
Support Level
$1.74
Resistance Level
$5.96
Current Trend
Sideways
Technical data as of
Jun 12, 2026
Fundamental Context
Forward P/E (Next Year Est.)
-0.80
Wall Street Target
$10.00
(+179.3%)
Share & Embed Analysis
Last updated: June 15, 2026 2:03 AM ET
Data refreshes hourly during market hours. Next update: 3:03 AM
Data refreshes hourly during market hours. Next update: 3:03 AM
🔥 Top Stocks Breaking Out Now
| Ticker | Score | Recommendation | Change % |
|---|
Technical Signals Check
Is INDP showing a specific setup today?
Insider Activity (6 Months)
0
Buys
0
Sells
0
Net
NEUTRAL
Top Rated Biotechnology Stocks
Top-rated stocks in Biotechnology by analyst ratings.
| Stock | Analyst Consensus | Analyst Target | Tradestie Score |
|---|---|---|---|
|
NTLA
Intellia Therapeutics Inc |
STRONG BUY
29 analysts |
$27 | 50 HOLD |
|
ONC
BeiGene, Ltd. |
STRONG BUY
24 analysts |
$412 | 51 HOLD |
|
AXSM
Axsome Therapeutics Inc |
STRONG BUY
19 analysts |
$275 | 61 BUY |
|
MLTX
MoonLake Immunotherapeut… |
STRONG BUY
16 analysts |
$28 | 60 HOLD |
|
BNTX
BioNTech SE |
STRONG BUY
21 analysts |
$123 | 54 HOLD |
